Nivolumab a chemoterapie (platinový dublet) vs. chemoterapie jako terapie 1. linie u pokročilého nemalobuněčného karcinomu plic s expresí PD-L1 < 1 % v nádoru: výsledky studie CheckMate 227

Hossein Borghaei, Matthew David Hellmann, Luis G. Paz-Ares, Suresh S. Ramalingam, Martin Reck, Kenneth John O’Byrne, Prabhu Bhagavatheeswaran, Faith Ellen Nathan, Julie R. Brah­mer

Fox Chase Cancer Center, Philadelphia, PA
Memorial Sloan Kettering Cancer Center, New York, NY
Hospital Universitario Doce de Octubre, Madrid, Spain
Winship Cancer Institute, Emory University, Atlanta, GA
LungenClinic Grosshansdorf, German Center for Lung Research, Grosshansdorf, Germany
Princess Alexandra Hospital Brisbane, Queensland, Australia
Bristol-Myers Squibb, Princeton, NJ
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD